The global marine biotechnology market size was exhibited at USD 5.9 billion in 2022 and is projected to hit around USD 11.73 billion by 2032, growing at a CAGR of 7.11% during the forecast period 2023 to 2032.
Key Pointers:
Marine Biotechnology Market Report Scope
Report Coverage |
Details |
Market Size in 2023 |
USD 6.32 Billion |
Market Size by 2032 |
USD 11.73 Billion |
Growth Rate from 2023 to 2032 |
CAGR of 7.11% |
Base year |
2022 |
Forecast period |
2023 to 2032 |
Segments covered |
By Source, By Application and By End User |
Regional scope |
North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
Marine Biotechnology is the field of science of producing products from aquatic organisms with the approaches of biotechnology, cell biology, molecular biology, and bioinformatics. It deals with the development of pharmaceutical drugs, enzymes and chemical products by exploring the ocean and marine resources. It is also referred to as blue biotechnology. It includes the use of techniques like bioremediation, bioprocessing, bioharvesting, and aquaculture with the application of bioreactors.
Applications of marine biotechnology include medicine, biofuels, environment, health management, reproduction, and nutrition. For example, Reproduction: Production of fish gonadotropin hormone by crude pituitary gland preparation using recombinant DNA technology, Nutrition: Transfer of glucose and hexokinase genes in the carnivorous fish for enhancing the carbohydrate uptake metabolism, Health improvement and management: Use of polymerase chain reaction (PCR) in disease diagnosis. The National Institute of Ocean Technology of India has prepared anti-aging cosmetics from deep-sea bacteria in July 2021.
As per the research, the application of sea-based ingredients in agriculture and cosmetics is in high demand fostering the marine biotechnology market growth. The nutritional supplements made from marine-derived products are in increasing demand leading to the growth of the marine biotechnology market. Discoveries and progress in the fields of aquaculture, fishery, and drug discovery development is the key driver for the market growth. Recently, Bluu Biosciences received funding for the production of fish products from cell culture. An increase in the demand and awareness of using aquatic organisms for healthy management paves way for the industry growth.
The market is segmented by type, technology, application, end-user, and region. The type segment is bifurcated into bio active substances and bio materials. The technology segment is bifurcated into isolation and cultivation of microorganisms, and culture-independent techniques. The application segment is based on aquaculture and food products, environment and human health, and drug discovery. The end-user segment is fragmented by food industry, pharmaceutical and biotechnology industry, chemical industry, and cosmetic industry. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Europe has the major share of the marine biotechnology market due to the government's support to use sea-based products. Thus the funding and investments by the government are the driving factor for the growth of the market. North America also has better and developed healthcare and research facilities coupled with biotechnology companies producing marine-based products, thus driving industry growth.
Some of the prominent players in the Marine Biotechnology Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Marine Biotechnology market.
By Source
By Application
By End User
By Region